In summary, CD148 may serve as a prognostic factor in gastric cancer, and its downregulation might be a molecular abnormality linked to oncogenesis and metastasis of gastric cancer through EGFR phosphorylation and subsequent downstream signaling activation. Here, PTPRJ is linked to gastric cancer.